Kynam Capital Management’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$170M Hold
2,922,335
10.78% 3
2025
Q4
$135M Sell
2,922,335
-149,253
-5% -$6.68M 8.78% 5
2025
Q3
$111M Hold
3,071,588
8.24% 5
2025
Q2
$99.9M Sell
3,071,588
-128,412
-4% -$4.21M 10.75% 2
2025
Q1
$121M Buy
3,200,000
+863,204
+37% +$69M 10.34% 2
2024
Q4
$191M Buy
2,336,796
+1,297,508
+125% +$129M 12.62% 2
2024
Q3
$119M Buy
1,039,288
+286,048
+38% +$25.8M 9.2% 2
2024
Q2
$56.9M Buy
753,240
+8,240
+1% +$561K 5.95% 9
2024
Q1
$50.9M Sell
745,000
-257,407
-26% -$17.8M 5.66% 7
2023
Q4
$63M Sell
1,002,407
-300,000
-23% -$15.6M 7.12% 4
2023
Q3
$66.4M Buy
1,302,407
+2,407
+0.2% +$119K 11.04% 3
2023
Q2
$64.9M Buy
1,300,000
+83,216
+7% +$3.94M 9.95% 5
2023
Q1
$45.6M Buy
1,216,784
+513,343
+73% +$21.8M 5.9% 5
2022
Q4
$33.7M Buy
703,441
+4,803
+0.7% +$188K 5.17% 5
2022
Q3
$16.8M Sell
698,638
-25,143
-3% -$637K 3.54% 9
2022
Q2
$15.7M Buy
723,781
+144,141
+25% +$3.34M 4.06% 9
2022
Q1
$14M Buy
579,640
+368,157
+174% +$8.04M 4.55% 8
2021
Q4
$5.03M Buy
+211,483
New +$4.92M 2.69% 14

Other funds holding PCVX